Cover Image

A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52)

Show other versions (1)
Saved in:
Bibliographic Details
Main Authors: Minckwitz, Gunter von (Author) , Conrad, Bettina (Author) , Reimer, Toralf (Author) , Decker, Thomas (Author) , Eidtmann, Holger (Author) , Eiermann, Wolfgang (Author) , Hackmann, John (Author) , Möbus, Volker (Author) , Marmé, Frederik (Author) , Potenberg, Jochem (Author) , Stickeler, Elmar (Author) , Simon, Eike (Author) , Thomssen, Christoph (Author) , Huober, Jens (Author) , Denkert, Carsten (Author) , Alfer, Joachim (Author) , Jackisch, Christian (Author) , Nekljudova, Valentina (Author) , Burchardi, Nicole (Author) , Loibl, Sibylle (Author)
Format: Article (Journal)
Language:English
Published: 2015
In: Cancer
Year: 2015, Volume: 121, Issue: 20, Pages: 3639-3648
ISSN:0008-543X
Online Access: Get full text
Author Notes:Gunter von Minckwitz, MD; Bettina Conrad, MD; Toralf Reimer, MD; Thomas Decker, MD; Holger Eidtmann, MD; Wolfgang Eiermann, MD; John Hackmann, MD; Volker Möbus, MD; Frederik Marmé, MD; Jochem Potenberg, MD; Elmar Stickeler, MD; Eike Simon, MD; Christoph Thomssen, MD; Jens Huober, MD; Carsten Denkert, MD;Joachim Alfer, MD; Christian Jackisch, MD; Valentina Nekljudova, PhD; Nicole Burchardi, PhD; and Sibylle Loibl, MD; for the German Breast Group Investigators
Description
ISSN:0008-543X

Similar Items